Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism

Breckwoldt, 1989, Hirsutism, its pathogenesis, Hum Reprod, 4, 601, 10.1093/oxfordjournals.humrep.a136950

Barbieri, 1990, Hyperandrogenic disorders, Clin Obstet Gyne-col, 33, 640, 10.1097/00003081-199009000-00028

Toscano, 1991, Hirsutism: pilosebaceous unit disregulation—reductase activity in role of peripheral and glandular factors, J Endocrinol Invest, 14, 153, 10.1007/BF03350293

Serafini, 1985, Increased 5-α reductase activity in idiopathic hirsutism, Fertil Steril, 43, 74, 10.1016/S0015-0282(16)48320-2

Mauvais-Jarvis, 1977, Androgen metabolism in human skin: mechanism of control, 229

Barnes, 1991, Adrenal dysfunction and hirsutism, Clin Obstet Gynecol, 34, 827, 10.1097/00003081-199112000-00020

Aiman, 1991, Virilizing ovarian tumors, Clin Obstet Gynecol, 34, 835, 10.1097/00003081-199112000-00021

Schriock, 1991, Treatment of hirsutism, Clin Obstet Gynecol, 34, 852, 10.1097/00003081-199112000-00023

Givens, 1974, Dynamics of suppression and recovery of plasma LH, FSH, androstenedi-one and testosterone in polycystic ovarian disease using an oral contraceptive, J Clin Endocrinol Metab, 38, 727, 10.1210/jcem-38-5-727

Wiebe, 1984, Effect of an oral contraceptive on adrenal and ovarian androgenic steroids, Obstet Gynecol, 63, 12

Aydinlik, 1990, Long-term therapy of signs of androgenization with a low-dosed anti-androgen-oestrogen combination, Clin Trials J, 27, 392

Falsetti, 1986, A new association of ethinyl estradiol (0.035mg) and cyproterone acetate (2mg) in the therapy of polycystic ovary syndrome, Acta Eur Fertil, 17, 19

Cumming, 1982, Treatment of hirsutism with spironolactone, JAMA, 247, 1295, 10.1001/jama.1982.03320340049034

Cusan, 1988, Treatment of hirsutism with the pure antiandrogen flutamide, Recent Res Gynecol Endocrinol, 1, 577

Rittmaster, 1985, Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women, J Clin Endocrinol Metab, 61, 462, 10.1210/jcem-61-3-462

Adashi, 1990, Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism, Fertil Steril, 53, 765, 10.1016/S0015-0282(16)53508-0

Andreiko, 1986, Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin), J Clin Endocrinol Metab, 63, 854, 10.1210/jcem-63-4-854

Ferriman, 1961, Clinical assessment of body hair growth in women, J Clin Endocrinol Metab, 21, 1440, 10.1210/jcem-21-11-1440

Orsini, 1983, Ultrasound monitoring of ovarian follicular development: a comparison of real time and static scanning techniques, J Clin Ultrasound, 11, 207, 10.1002/jcu.1870110407

Lobo, 1991, Hirsutism in polycystic ovary syndrome: current concepts, Clin Obstet Gynecol, 34, 817, 10.1097/00003081-199112000-00019

Judd, 1992, Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy, Am J Obstet Gynecol, 166, 752, 10.1016/0002-9378(92)91708-I

Leather, 1993, The prevention of bone loss in young women treated with GnRH-analogues with "add-back" estrogen therapy, Obstet Gynecol, 81, 104

Buchanan, 1988, Effect of excess endogenous androgens on bone density in young women, J Clin Endocrinol Metab, 67, 937, 10.1210/jcem-67-5-937

Andreiko, 1987, Therapeutic uses of gonadotropin-releasing hormone analogs, Obstet Gynecol Surv, 42, 1, 10.1097/00006254-198701000-00001